Ling Chen-Ling

Guangzhou International Bio Island
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Long-acting lenacapavir is a breakthrough for preventing HIV infection, but HIV vaccine research must continue.

Long-acting lenacapavir is a breakthrough for preventing HIV infection, but HIV vaccine research must continue.

Journal: Frontiers of medicine
Published: February 05, 2025

A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses.

A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses.

Journal: Journal of nanobiotechnology
Published: December 14, 2024

A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.

A single-dose circular RNA vaccine prevents Zika virus infection without enhancing dengue severity in mice.

Journal: Nature communications
Published: March 07, 2024

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies.

Intranasal adenovirus-vectored Omicron vaccine induced nasal immunoglobulin A has superior neutralizing potency than serum antibodies.

Journal: Signal transduction and targeted therapy
Published: February 20, 2024

Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants.

Antibodies utilizing VL6-57 light chains target a convergent cryptic epitope on SARS-CoV-2 spike protein and potentially drive the genesis of Omicron variants.

Journal: Nature communications
Published: September 06, 2023

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike.

An unconventional VH1-2 antibody tolerates escape mutations and shows an antigenic hotspot on SARS-CoV-2 spike.

Journal: Cell reports
Published: June 22, 2023

Correction To: Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.

Correction To: Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.

Journal: Signal transduction and targeted therapy
Published: May 24, 2023

Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.

Intranasal booster using an Omicron vaccine confers broad mucosal and systemic immunity against SARS-CoV-2 variants.

Journal: Signal transduction and targeted therapy
Published: November 26, 2022

Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.

Blood unconjugated bilirubin and tacrolimus are negative predictors of specific cellular immunity in kidney transplant recipients after SAR-CoV-2 inactivated vaccination.

Journal: Scientific reports
Published: August 17, 2022

Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants.

Somatically hypermutated antibodies isolated from SARS-CoV-2 Delta infected patients cross-neutralize heterologous variants.

Journal: Nature communications
Published: June 17, 2022

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope.

SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope.

Journal: Nature microbiology
Published: February 28, 2022

Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity.

Shell-mediated phagocytosis to reshape viral-vectored vaccine-induced immunity.

Journal: Biomaterials
Published: April 14, 2021
Showing 1-12 of 23

Last Updated: 09/26/2026